Mould Toxicity: 10 Symptoms You Shouldn't Ignore
If you've been dealing with a constellation of unexplained symptoms — fatigue that doesn't improve with rest, a foggy head, recurring sinus infections, or gut problems that no test seems to explain — mould toxicity may be worth taking seriously.
This isn't about being alarmist. It's about recognising a pattern that is increasingly supported by the scientific literature, and that is routinely missed in conventional clinical settings. Mould toxicity (or mould illness) refers to the multi-system health consequences of exposure to mould and the toxic compounds they produce — called mycotoxins. These are secondary metabolites released by certain mould species — most commonly Aspergillus, Stachybotrys, Penicillium, and Fusarium — and they can enter the body through inhalation, ingestion, and even skin contact.
What makes mould illness so challenging to identify is that its symptoms are wide-ranging, non-specific, and often attributed to other conditions. Research published in the peer-reviewed literature has characterised Chronic Inflammatory Response Syndrome (CIRS) — the most severe form of mould-related illness — as an underdiagnosed, multi-system condition involving dysregulation of the innate immune system that may affect up to 25% of the population. This isn't a fringe concept. The challenge is that most clinicians haven't been trained to look for it.
Below are ten of the most clinically significant symptoms associated with mould toxicity, each grounded in published research.
1. Chronic Fatigue and Post-Exertional Malaise
Fatigue is probably the most commonly reported symptom in mould-exposed individuals, and it tends to be the kind of tiredness that doesn't respond to sleep.
Exposure to mycotoxins has demonstrated positive associations with fatigue, musculoskeletal pain, headaches, anxiety, mood changes, and cognitive impairment. What makes mould-related fatigue distinctive is its depth. Many patients describe it as an "all-over heaviness" — one that gets worse with activity rather than better. Research has noted that chronic mould exposure can lead to a wide range of neurological consequences including general debilitating pain, fever, memory loss, depression, mood swings, sleep disturbances, anxiety, and chronic fatigue.
This fatigue pattern overlaps significantly with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and CIRS is frequently misdiagnosed as ME/CFS, which means many patients with an underlying mould exposure are receiving a diagnosis without ever addressing the root cause.
Clinical note: If your fatigue is accompanied by several other symptoms on this list, particularly cognitive symptoms and immune issues, mould exposure is worth investigating.
2. Brain Fog and Cognitive Impairment
Brain fog is perhaps the most debilitating cognitive symptom associated with mould illness. Patients typically describe difficulty concentrating, word-finding problems, memory lapses, and a feeling of thinking "through cotton wool."
In research assessing the neuropsychological effects of exposure to mixed colonies of toxigenic moulds, patients reported moderate to severe levels of cognitive, physical, and emotional symptoms, with electroencephalography results showing hypoactivation in the frontal cortex — a pattern consistent with impaired functioning across multiple cognitive tasks when compared to premorbid estimates of intelligence.
Mycotoxins can enter the brain via the olfactory system — the nerve fibres that run from the nose directly into the brain — making inhalation a particularly direct route of neurological exposure. Mycotoxins induce toxicological effects similar to those associated with brain disorders, including oxidative stress and inflammation, and mould enters the body through the nose via olfactory neurons, which directly communicate with the brain.
This is why cognitive symptoms in a water-damaged building environment deserve serious clinical investigation, not dismissal.
3. Chronic Sinus Problems and Nasal Congestion
Persistent sinusitis that doesn't resolve with antibiotics is a hallmark presentation of mould-related illness. The sinuses are often the primary port of entry for mould spores and mycotoxins — and in susceptible individuals, they can become a reservoir for ongoing exposure.
Research has characterised chronic rhinosinusitis as an inflammatory disorder of the nose and paranasal sinuses in which fungi may be responsible for certain forms, with an aberrant immune response to ubiquitous fungi proposed to explain development in susceptible individuals. Crucially, this means standard antibiotic treatment doesn't address the underlying driver.
A particularly relevant concept here is MARCoNS — Multiply Antibiotic Resistant Coagulase Negative Staphylococci — a biofilm-forming bacterial colonisation of the nasal passages that has been documented in association with mould illness. Research has proposed that naso-sinus fungal biofilm may be a key driver of chronic illness associated with mould and mycotoxin exposure.
If you've had multiple courses of antibiotics for sinus infections with little lasting improvement, or if your ENT has found nothing structurally wrong, mould-related immune dysregulation is a clinically relevant possibility.
4. Symptoms That Improve When You Leave the Building
This is one of the most diagnostically informative patterns in mould-related illness, and it is often overlooked simply because nobody asks the right question. Do your symptoms improve on holiday? At weekends away? When you're not at home or in your office?
In cases of CIRS from water-damaged buildings, symptoms can be intermittent but when the exposure is a home, school, or workplace, they become chronic and worsen over time as each re-exposure trains the innate immune system into a more heightened inflammatory response.
This pattern — feeling better away from a building and worse upon return — is not psychosomatic. It reflects a real immunological sensitisation process. Recovery of immune, vascular, and endocrine function is dependent on removal from the offending environment.
If you notice this pattern in yourself or a family member, it is worth seriously considering the possibility that the building you are spending the most time in may be implicated in your symptoms.
5. Gut Symptoms: Bloating, IBS, and Digestive Disruption
The connection between mould toxicity and gut health is one of the most underappreciated in clinical practice. Research has demonstrated that mycotoxins downregulate mucin and tight junction proteins, increasing gut permeability in a pattern consistent with inflammatory bowel disease, and that mycotoxin exposure is associated with alterations in the gut microbiome balance and promotion of intestinal inflammation.
In other words, the gut barrier — your primary physical defence against systemic inflammation — can be directly compromised by mycotoxins. The downstream consequences include dysbiosis, increased intestinal permeability ("leaky gut"), heightened food sensitivities, and IBS-like symptoms.
Mycotoxins impair gut health at both structural and functional levels — disrupting the balance of beneficial and pathogenic bacteria, increasing intestinal permeability, interfering with nutrient absorption, generating oxidative stress and inflammation, and increasing susceptibility to bacterial, viral, and parasitic gut infections.
If your gut symptoms have been attributed to IBS without a clear trigger, and you also experience several other symptoms on this list, mould toxicity is a clinically plausible underlying driver worth investigating.
6. Immune Dysregulation and Frequent Infections
One of the more paradoxical features of mould illness is that it can simultaneously over-activate and suppress different arms of the immune system. The result is an individual who catches every cold going, struggles to clear infections, and may experience reactivation of latent viruses — while at the same time having inflammatory markers that are elevated or dysregulated.
Research has illustrated how mycotoxins can trigger the onset or exacerbation of chronic inflammatory diseases, autoimmune disorders, and immune dysregulation — and has highlighted that exposure in individuals with pre-existing immune dysfunction is of particular concern.
Studies have found that the most common immune abnormality in mycotoxin-exposed patients is diminished natural killer cell (NK) function — a critical branch of innate immunity responsible for identifying and clearing virally infected and tumour cells. nih
If you notice that you're getting ill more easily than you used to, that infections linger longer, or that you're reacting to things that previously didn't bother you, chronic mould exposure deserves to be on the clinical radar.
7. Musculoskeletal Pain, Joint Stiffness, and Headaches
Widespread body pain, stiffness on waking, and unexplained headaches are frequently reported by mould-exposed individuals. These symptoms arise not because mould directly damages tissues, but because the systemic inflammatory response triggered by mycotoxins creates a low-grade but persistent inflammatory environment throughout the body.
Research has documented that human exposure to mould, mycotoxins, and water-damaged buildings can cause neurologic and neuropsychiatric signs and symptoms, many of which can partly mimic classic neurological disorders including pain syndromes, movement disorders, and disorders of balance and coordination.
Headache, general debilitating pains, and chronic fatigue are among the documented neurological consequences of chronic exposure to toxigenic mould.
What is clinically important here is the pattern: if your musculoskeletal pain is diffuse, fluctuates, and is accompanied by cognitive or immune symptoms, it is unlikely to respond to pain management alone. The underlying inflammatory driver needs to be identified.
8. Sleep Disturbances and Non-Restorative Sleep
Difficulty falling asleep, staying asleep, or waking unrefreshed are common in mould-exposed patients. This is partly neurological — mycotoxins disrupt the normal signalling cascades involved in sleep-wake regulation — and partly inflammatory, as elevated cytokines are known to fragment sleep architecture.
Research has concluded that chronic exposure to toxigenic mould could lead to abnormal natural killer cell activity with neurological consequences including sleep disturbances, depression, mood swings, and anxiety.
CIRS causes a cascade of inflammatory and hormonal changes that result in symptoms including fatigue, pain, gastrointestinal and neurological symptoms, and sleep disturbances.
Non-restorative sleep in turn compounds cognitive symptoms, immune suppression, and pain sensitivity — creating a vicious cycle that is difficult to break without identifying and addressing the underlying environmental trigger.
9. Mood Changes, Anxiety, and Low Mood
The impact of mould toxicity on mental health is one of its most distressing and least recognised consequences. Patients often describe a change in their emotional baseline — increased anxiety, low mood, emotional volatility, a sense of disconnection — which can lead to psychiatric diagnoses that address the symptom rather than the cause.
Mycotoxin exposure has demonstrated positive associations with anxiety, mood disturbance, and depression in addition to cognitive impairments.
The mechanism is partly neuroinflammatory — mycotoxins promote inflammatory cytokine release in the brain — and partly neuroendocrine, as chronic exposure disrupts the HPA axis and normal cortisol regulation. Mycotoxins disturb hormonal balance in the body and reduce tolerance to any type of stress.
If mood changes emerged alongside other physical symptoms — particularly fatigue, brain fog, or sinus problems — and don't have a clear psychological trigger, it is worth considering whether a biological driver, including mould exposure, may be contributing.
10. Skin Rashes, Sensitivity, and Unexplained Reactions
The skin is often one of the last systems considered in mould illness, but it can be an early indicator of underlying immune dysregulation. Rashes, eczema flares, hives, and heightened skin sensitivity — particularly to products that were previously tolerated — are reported across the mould illness literature.
Mycotoxins can be absorbed from the skin, airways, and intestinal lining, and individuals exposed to mould present with symptoms affecting multiple organs including the lungs, musculoskeletal system, and both central and peripheral nervous systems.
Mast cell activation — a key mechanism in mould illness — is particularly relevant here. Aspergillus can activate mast cells to degranulate and release chemical mediators, and elevated mould and mycotoxin levels should be considered a cause of mast cell activation syndrome in anyone with a suspected history of mould exposure.
Mast cell activation can produce a wide array of skin symptoms including urticaria, flushing, and dermographism. If your skin is increasingly reactive alongside other systemic symptoms, this inflammatory mechanism is worth exploring with an appropriately trained clinician.
The Common Thread: Systemic Inflammation and Innate Immune Dysregulation
What unites all ten of these symptoms is not that they are caused by mould in a simple, linear way — but that they are consistent with the sustained, dysregulated inflammatory response that mould and mycotoxin exposure can trigger in genetically susceptible individuals.
It is worth noting that the science here is not without debate. Some published commentary has argued that the association between indoor mould exposure and the range of nonspecific symptoms attributed to "toxic mould syndrome" lacks sufficient evidence, and this is a position held by some academic medical institutions. The reality, as with many areas of complex, multi-system illness, is that the evidence base continues to evolve — and that clinical experience often runs ahead of consensus. PubMed
What we can say with confidence is that mould and mycotoxin exposure has documented effects on the gut barrier, the immune system, the nervous system, the sinuses, and the hormonal milieu. When these systems are disrupted together, the clinical picture can be complex — and the path forward requires looking at the whole person, not just the individual symptom.
What to Do If You Recognise These Symptoms
If several of the symptoms above resonate — especially if they are accompanied by a known or suspected history of living or working in a damp or water-damaged building — the following steps are clinically relevant:
1. Assess your environment. Consider whether your symptoms began or worsened after moving to a property, or improve significantly when you are away from it. Look for visible mould, persistent damp, musty smells, condensation, or a history of water damage.
2. Consider functional testing. Urinary mycotoxin testing, inflammatory biomarkers (C4a, TGF-β1, MMP-9), and visual contrast sensitivity testing are used by trained functional medicine practitioners to build a clinical picture of mould-related illness.
3. Seek a practitioner experienced in this area. Mould illness is poorly understood in conventional medicine and frequently misdiagnosed. Functional and integrative practitioners with specific training in CIRS and mycotoxin illness are better placed to investigate and address the full picture.
4. Don't just treat symptoms in isolation. Treating fatigue, gut issues, or skin rashes without identifying the environmental driver is unlikely to produce lasting results.
If you're concerned that mould toxicity may be contributing to your symptoms, check out our course Mould Mastery that walks through every step of recovery.
References (PubMed/PMC)
Ratnaseelan AM et al. Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune Processes. Clinical Therapeutics. 2018. PMID: 29880330
Empting LD. Neurologic and neuropsychiatric syndrome features of mold and mycotoxin exposure. Toxicol Ind Health. 2009. PMID: 19854819
Brewer JH et al. Detection of Mycotoxins in Patients with Chronic Fatigue Syndrome. Toxins. 2013. PMC3705282
Calderón-Ezquerro MC et al. Mold and Mycotoxin Exposure and Brain Disorders. J Integr Neurosci. 2023.
Kraft S & Buchenauer L & Polte T. Mold, Mycotoxins and a Dysregulated Immune System: A Combination of Concern? Int J Mol Sci. 2021. PMC8619365
Nnorom CG et al. Chronic inflammatory response syndrome: a review of the evidence of clinical efficacy of treatment. PMC11623837
Unravelling the impact of mycotoxins on gut health: implications for inflammatory bowel disease. ScienceDirect, 2025.
Brewer JH, Thrasher JD, Hooper D. Chronic illness associated with mold and mycotoxins: Is naso-sinus fungal biofilm the culprit? Toxins. 2013. PMID: 24434834
Peraica M et al. The Neurological Significance of Abnormal Natural Killer Cell Activity in Chronic Toxigenic Mold Exposures. PMC5974762
